Retrospective analysis of laboratory abnormalities in patients prescribed terbinafine for onychomycosis

J Am Acad Dermatol. 2021 Feb;84(2):497-499. doi: 10.1016/j.jaad.2020.04.172. Epub 2020 May 7.

Authors

Yu Wang¹, Solomon Geizhals², Shari R Lipner³

Affiliations

¹ State University of New York Stonybrook Medical School, Stonybrook, New York.
² State University of New York Downstate Medical School, Brooklyn, New York.
³ Weill Cornell Medicine, Department of Dermatology, New York, New York. Electronic address: shl9032@med.cornell.edu.

PMID: 32387655
DOI: 10.1016/j.jaad.2020.04.172

No abstract available

Publication types

Letter

MeSH terms

Administration, Oral
Adult
Aged
Aged, 80 and over
Alanine Transaminase
Antifungal Agents / administration & dosage
Antifungal Agents / adverse effects*
Aspartate Aminotransferases
Chemical and Drug Induced Liver Injury / blood
Chemical and Drug Induced Liver Injury / diagnosis*
Chemical and Drug Induced Liver Injury / etiology
Drug Monitoring / statistics & numerical data*
Female
Humans
Liver Function Tests / statistics & numerical data
Male
Middle Aged
Onychomycosis / drug therapy*
Retrospective Studies
Terbinafine / administration & dosage
Terbinafine / adverse effects*
Treatment Outcome
Young Adult

Substances

Antifungal Agents
Aspartate Aminotransferases
Alanine Transaminase
Terbinafine